UroGen Pharma
URGN
URGN
80 hedge funds and large institutions have $287M invested in UroGen Pharma in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less capital invested
Capital invested by funds: $382M → $287M (-$95M)
25% less call options, than puts
Call options by funds: $3.72M | Put options by funds: $4.96M
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
80
Holding in Top 10
2
Calls
$3.72M
Puts
$4.96M
Top Buyers
| 1 | +$6.79M | |
| 2 | +$3.88M | |
| 3 | +$1.91M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.74M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$1.74M |
Top Sellers
| 1 | -$3.24M | |
| 2 | -$1.87M | |
| 3 | -$1.68M | |
| 4 |
SG Americas Securities
New York
|
-$1.35M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$934K |